Bactericidal antibiotics temporarily increase inflammation and worsen acute kidney injury in experimental sepsis

Critical Care Medicine

Volumn 40, Issue 2, 2012, Pages 538-543

  Peng, Zhi Yong ^a   Wang, Hong Zhi ^b   Srisawat, Nattachai ^a   Wen, Xiaoyan ^a   Rimmelé, Thomas ^a   Bishop, Jeffery ^a   Singbartl, Kai ^a   Murugan, Raghavan ^a   Kellum, John A ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

Author keywords

acute kidney injury; acute renal failure; sepsis

Indexed keywords

BACTERICIDE; CREATININE; INTERLEUKIN 6; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; SULTAMICILLIN;

ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE COURSE; DISEASE SEVERITY; HISTOLOGY; INFLAMMATION; KIDNEY FUNCTION; LIVER INJURY; MALE; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; SEPSIS; SURVIVAL;

ACUTE KIDNEY INJURY; AMPICILLIN; ANIMALS; ANTI-BACTERIAL AGENTS; DISEASE MODELS, ANIMAL; IMMUNOHISTOCHEMISTRY; INFLAMMATION; KAPLAN-MEIER ESTIMATE; MALE; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; REFERENCE VALUES; RISK ASSESSMENT; SEPSIS; STATISTICS, NONPARAMETRIC; SULBACTAM; SURVIVAL RATE; TIME FACTORS;

EID: 84856195007     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e31822f0d2e     Document Type: Article

References (37)

1. Bagshaw SM, Uchino S, Bellomo R, et al: Septic acute kidney injury in critically ill patients: Clinical characteristics and outcomes. Clin J Am Soc Nephrol 2007; 2:431-439
2. Uchino S, Kellum JA, Bellomo R, et al: Acute renal failure in critically ill patients: A multinational, multicenter study. JAMA 2005; 294:813-818
3. Barrantes F, Feng Y, Ivanov O, et al: Acute kidney injury predicts outcomes of noncritically ill patients. Mayo Clin Proc 2009; 84:410-416
4. Bagshaw SM, George C, Dinu I, et al: A multi-centre evaluation of the RIFLE criteria for early acute kidney injury in critically ill patients. Nephrol Dial Transplant 2008; 23: 1203-1210
5. Chen YC, Jenq CC, Tian YC, et al: Rifle classification for predicting in-hospital mortality in critically ill sepsis patients. Shock 2009; 31:139-145
6. Hjalmarson A, Goldstein S, Fagerberg B, et al: Effects of controlled-release metoprolol on total mortality, hospitalizations, and wellbeing in patients with heart failure: The Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group. JAMA 2000; 283: 1295-1302
7. Langenberg C, Bagshaw SM, May CN, et al: The histopathology of septic acute kidney injury: A systematic review. Crit Care 2008; 12:R38
8. Bagshaw SM, Langenberg C, Wan L, et al: A systematic review of urinary findings in experimental septic acute renal failure. Crit Care Med 2007; 35:1592-1598
9. Kellum JA: Impaired renal blood flow and the 'spicy food' hypothesis of acute kidney injury. Crit Care Med 2011; 39:901-903
10. Mehta RL, Bouchard J, Soroko SB, et al; Program to Improve Care in Acute Renal Disease (PICARD) Study Group: Sepsis as a cause and consequence of acute kidney injury: Program to Improve Care in Acute Renal Disease. Intensive Care Med. 2011; 37: 241-248
11. Murugan R, Karajala-Subramanyam V, Lee M, et al: Acute kidney injury in non-severe pneumonia is associated with an increased immune response and lower survival. Kidney Int 2010; 77:527-535
12. Chawla LS, Seneff MG, Nelson DR, et al: Elevated plasma concentrations of IL-6 and elevated APACHE II score predict acute kidney injury in patients with severe sepsis. Clin J Am Soc Nephrol 2007; 2:22-30
13. Loscalzo J, Fauci AS, Braunwald E, et al: Harrison's Principles of Internal Medicine. Seventeenth Edition. Dubuque, IA, McGraw-Hill Medical, 2008, pp 1048-1067
14. Alkharfy KM, Kellum JA, Matzke G: Unintended immunomodulation: Part II. Effects of pharmacological agents on cytokine activity. Shock 2000; 13:346-360
15. Garnacho-Montero J, Aldabo-Pallas T, Garnacho-Montero C, et al: Timing of adequate antibiotic therapy is a greater determinant of outcome than are TNF and IL-10 polymorphisms in patients with sepsis. Crit Care 2006; 10:R111
16. Vyas D, Javadi P, Dipasco PJ, et al: Early antibiotic administration but not antibody therapy directed against IL-6 improves survival in septic mice predicted to die on basis of high IL-6 levels. Am J Physiol Regul Integr Comp Physiol 2005; 289:R1048-R1053
17. Peng Z, Wang H, Carter M, et al: Hemoadsorption improves long-term survival after sepsis in the rats. Crit Care Med 2008; 36(Suppl):A1
18. Bellomo R, Ronco C, Kellum JA, et al; Acute Dialysis Quality Initiative Workgroup: Acute renal failure-Definition, outcome measures, animal models, fluid therapy and information technology needs: The Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004; 8:R204-R212
19. Vidal V, Scragg IG, Cutler SJ, et al: Variable major lipoprotein is a principal TNFinducing factor of louse-borne relapsing fever. Nat Med 1998; 4:1416-1420
20. Kellum JA, Kong L, Fink MP, et al: Understanding the inflammatory cytokine response in pneumonia and sepsis. Arch Intern Med 2007; 167:1655-1633
21. Song M, Kellum JA: Interleukin-6. Crit Care Med 2005; 33:S463-S465
22. Gismondo MR, Chisari G, Lo-Bue AM: Effects of ampicillin and sulbactam/ampicillin on the immune system. J Int Med Res 1991; 19(Suppl 1):24A-28A
23. Van Den Berg C, de Neeling AJ, Schot CS, et al: Delayed antibiotic-induced lysis of Escherichia coli in vitro is correlated with enhancement of LPS release. Scand J Infect Dis 1992; 24:619-627
24. Van Vlem B, Vanholder R, De Paepe P, et al: Immunomodulating effects of antibiotics: Literature review. Infection 1996; 24: 275-291
25. Holzheimer RG: The significance of endotoxin release in experimental and clinical sepsis in surgical patients-Evidence for antibiotic-induced endotoxin release? Infection 1998; 26:77-84
26. Yamamoto A, Sakai T, Ochiai M, et al: Augmenting effect of antibiotics on endotoxin activity may cause a safety problem. Microbiol Immunol 2004; 48:97-102
27. Wen X, Murugan R, Peng Z, et al: Pathophysiology of acute kidney injury: A new perspective. Contrib Nephrol 2010; 165:39-45
28. Coca SG, King JT Jr, Rosenthal RA, et al: The duration of postoperative acute kidney injury is an additional parameter predicting longterm survival in diabetic veterans. Kidney Int 2010; 78:926-933
29. Soni SS, Cruz D, Bobek I, et al: NGAL: A biomarker of acute kidney injury and other systemic conditions. Int Urol Nephrol 2010; 42:141-150
30. Srisawat N, Murugan R, Lee M, et al: Plasma neutrophil gelatinase-associated lipocalin predicts recovery from acute kidney injury following community-acquired pneumonia. Kidney Int 2011 Jun 15 [Epub ahead of print]
31. Leung JC, Lam MF, Tang SC, et al: Roles of neutrophil gelatinase-associated lipocalin in continuous ambulatory peritoneal dialysisrelated peritonitis. J Clin Immunol 2009; 29: 365-378
32. Xu SY, Pauksen K, Venge P: Serum measurements of human neutrophil lipocalin (HNL) discriminate between acute bacterial and viral infections. Scand J Clin Lab Invest 1995; 55:125-131
33. Martensson J, Bell M, Oldner A, et al: Neutrophil gelatinase-associated lipocalin in adult septic patients with and without acute kidney injury. Intensive Care Med 2010; 36: 1333-1340
34. Bennett M, Dent CL, Ma Q, et al: Urine NGAL predicts severity of acute kidney injury after cardiac surgery: A prospective study. Clin J Am Soc Nephrol 2008; 3:665-673
35. Hubbard WJ, Choudhry M, Schwacha MG, et al: Cecal ligation and puncture. Shock 2005; 24(Suppl 1):52-57
36. Maier S, Traeger T, Entleutner M, et al: Cecal ligation and puncture versus colon ascendens stent peritonitis: Two distinct animal models for polymicrobial sepsis. Shock 2004; 21:505-511
37. Vianna RC, Gomes RN, Bozza FA, et al: Antibiotic treatment in a murine model of sepsis: Impact on cytokines and endotoxin release. Shock 2004; 21:115-120